The Effect of Ozone Therapy for Lumbar Herniated Disc

NCT ID: NCT00566007

Last Updated: 2019-08-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE2

Total Enrollment

156 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-12-31

Study Completion Date

2014-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the efficacy (vs. placebo) of ozone infiltration and its effectiveness in comparison with micro discectomy in the treatment of lumbar herniated disc with criteria for surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lumbar Herniated Disc

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Discectomy/micro discectomy

Group Type ACTIVE_COMPARATOR

Discectomy/ micro discectomy

Intervention Type PROCEDURE

Standard discectomy or micro discectomy

Ozone therapy

Intervention Type DRUG

Infiltration of intradiscal ozone: O3/O2 in a 27 micrograms/ml concentration + foraminal infiltration of O3/O2 + corticoid + anesthetic

Oxygen therapy

Intervention Type DRUG

Intradiscal oxygen therapy: O3/O2 at a concentration of 0 micrograms/ml (only oxygen) + foraminal infiltration of O2 + corticoid + anesthetic

2

Intradiscal ozone infiltration

Group Type ACTIVE_COMPARATOR

Ozone therapy

Intervention Type DRUG

Infiltration of intradiscal ozone: O3/O2 in a 27 micrograms/ml concentration + foraminal infiltration of O3/O2 + corticoid + anesthetic

Oxygen therapy

Intervention Type DRUG

Intradiscal oxygen therapy: O3/O2 at a concentration of 0 micrograms/ml (only oxygen) + foraminal infiltration of O2 + corticoid + anesthetic

3

Intradiscal oxygen infiltration (control arm)

Group Type ACTIVE_COMPARATOR

Oxygen therapy

Intervention Type DRUG

Intradiscal oxygen therapy: O3/O2 at a concentration of 0 micrograms/ml (only oxygen) + foraminal infiltration of O2 + corticoid + anesthetic

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Discectomy/ micro discectomy

Standard discectomy or micro discectomy

Intervention Type PROCEDURE

Ozone therapy

Infiltration of intradiscal ozone: O3/O2 in a 27 micrograms/ml concentration + foraminal infiltration of O3/O2 + corticoid + anesthetic

Intervention Type DRUG

Oxygen therapy

Intradiscal oxygen therapy: O3/O2 at a concentration of 0 micrograms/ml (only oxygen) + foraminal infiltration of O2 + corticoid + anesthetic

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of herniated disc by surgeons from participating hospitals
* Sciatic pain of 5 or more on Visual Analogue Scale
* Pain radiated to appropriate area according to herniated disc
* On waiting list for disc surgery at one of participating hospitals

Exclusion Criteria

* Inability to fill out questionnaires (VAS, Roland Morris, SF12)
* Calcified or migrated herniated disc
* Herniated disc with indications for laminectomy or arthrodesis
* Clinically relevant partial paralysis
* Simultaneous cervical and dorsal symptomatic herniated discs
* Previous lumbar spine surgery
* Presence of other spinal pathology
* Significant glucose-6-phosphate-dehydrogenase deficit
* Allergy to ozone
* Treatment with oral anticoagulants
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fondo de Investigacion Sanitaria

OTHER

Sponsor Role collaborator

Hospital Negrín

UNKNOWN

Sponsor Role collaborator

Hospital Son Llatzer

OTHER

Sponsor Role collaborator

Servicio de Salud de las Islas Baleares (Ib-Salut)

UNKNOWN

Sponsor Role collaborator

Kovacs Foundation

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Francisco M Kovacs, MD, PhD

Role: STUDY_CHAIR

Kovacs Foundation, Palma de Mallorca, 07012, Spain

Bernardino Clavo, MD

Role: STUDY_DIRECTOR

Hospital Negrín, Las Palmas de Gran Canaria, 35010 Spain

Francisco Robaina, MD

Role: PRINCIPAL_INVESTIGATOR

Hospital Negrín, Las Palmas de Gran Canaria 35010 Spain

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Negrín

Las Palmas de Gran Canaria, Canary Islands, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

References

Explore related publications, articles, or registry entries linked to this study.

Andreula CF, Simonetti L, De Santis F, Agati R, Ricci R, Leonardi M. Minimally invasive oxygen-ozone therapy for lumbar disk herniation. AJNR Am J Neuroradiol. 2003 May;24(5):996-1000.

Reference Type BACKGROUND
PMID: 12748111 (View on PubMed)

Bonetti M, Fontana A, Cotticelli B, Volta GD, Guindani M, Leonardi M. Intraforaminal O(2)-O(3) versus periradicular steroidal infiltrations in lower back pain: randomized controlled study. AJNR Am J Neuroradiol. 2005 May;26(5):996-1000.

Reference Type BACKGROUND
PMID: 15891150 (View on PubMed)

Bocci V, Luzzi E, Corradeschi F, Paulesu L, Di Stefano A. Studies on the biological effects of ozone: 3. An attempt to define conditions for optimal induction of cytokines. Lymphokine Cytokine Res. 1993 Apr;12(2):121-6.

Reference Type BACKGROUND
PMID: 8324077 (View on PubMed)

Gibson JN, Grant IC, Waddell G. The Cochrane review of surgery for lumbar disc prolapse and degenerative lumbar spondylosis. Spine (Phila Pa 1976). 1999 Sep 1;24(17):1820-32. doi: 10.1097/00007632-199909010-00012.

Reference Type BACKGROUND
PMID: 10488513 (View on PubMed)

Bisshopp S, Linertova R, Carames MA, Szolna A, Jorge IJ, Navarro M, Melchiorsen B, Rodriguez-Diaz B, Gonzalez-Martin JM, Clavo B. Pain Relief, Disability, and Hospital Costs After Intradiscal Ozone Treatment or Microdiscectomy for Lumbar Disc Herniation: A 24-Month Real-World Prospective Study. J Clin Med. 2025 Jun 26;14(13):4534. doi: 10.3390/jcm14134534.

Reference Type DERIVED
PMID: 40648907 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FK-R-21

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Discogen for Low Back Pain
NCT06611397 RECRUITING NA
Treatment of Discogenic Back Pain
NCT02089139 TERMINATED NA